|
TRADITIONAL POSTERS |
|
|
Session Name |
Abstract Numbers |
Day |
|
Vascular Compliance |
0906 - 0911 |
Monday |
|
MRA: Other Techniques |
0912 - 0916 |
Tuesday |
|
Non-Contrast Enhanced MRA |
0917 - 0934 |
Wednesday |
|
Coronary MRA |
0935 - 0945 |
Thursday |
|
Vessel Wall Imaging
|
0946 - 0970 |
Monday |
|
MRA: Continuous Table Movement |
0971 - 0975 |
Tuesday |
|
Cardiac Function |
0976 - 0994 |
Wednesday |
|
Myocardial Perfusion |
0995 - 1007 |
Thursday |
|
Cardiac T2 & T2* |
1008 - 1019 |
Monday |
|
Animal Cardiac
Imaging |
1020 - 1031 |
Tuesday |
|
Contrast
Agents for MRA |
1032 - 1035 |
Wednesday |
|
Myocardial Viability Methods & Applications |
1036 - 1044 |
Thursday |
|
MR Safety: Fields |
1045 - 1055 |
Monday |
|
MR Safety: Devices |
1056 - 1064 |
Tuesday |
|
RF Coils for Human Imaging |
1065 - 1080 |
Wednesday |
|
RF Transmit Array Methods |
1081 - 1088 |
Thursday |
|
RF Transmit Array Hardware |
1089 - 1097 |
Monday |
|
RF Coils for Animal Imaging |
1098 - 1106 |
Tuesday |
|
RF Coil Technology: Non-Array |
1107 - 1118 |
Wednesday |
|
RF Systems & Components |
1119 - 1129 |
Thursday |
|
Transceiver & Control Systems |
1130 - 1147 |
Monday |
|
MR Systems, Magnets, Gradients, Shims |
1148 - 1177 |
Tuesday |
|
Computational Electromagnetics |
1178 - 1196 |
Wednesday |
|
MR-Guided Interventions (Non-Thermotherapy) |
1197 - 1217 |
Thursday |
|
Thermal Therapy & HIFU |
1218 - 1243 |
Monday |
|
B1 Mapping & Correction |
1244 - 1249 |
Thursday |
|
B0 Inhomogeneity Correction (Global/Local) |
1250 - 1258 |
Monday |
|
Parallel Imaging |
1259 - 1300 |
Tuesday |
|
Parallel RF Transmission Methods |
1301 - 1319 |
Wednesday |
|
RF Pulse Design |
1320 - 1327 |
Thursday |
|
High Field Imaging Methods |
1328 - 1333 |
Monday |
|
Pulse Sequence Design |
1334 -1349 |
Tuesday |
|
PROPELLER |
1350 -1356 |
Wednesday |
|
SSFP Methods |
1357 - 1361 |
Thursday |
|
EPI - Corrections |
1362 - 1366 |
Monday |
|
Flow Quantification Methods & Applications |
1367 - 1379 |
Tuesday |
|
Fat-Water Imaging |
1380 - 1388 |
Wednesday |
|
New Methods for Generating Contrast |
1389 - 1408 |
Thursday |
|
Relaxometry & Quantitation |
1409 - 1436 |
Monday |
|
New Contrast Mechanisms |
1437 - 1461 |
Tuesday |
|
Motion Correction |
1462 - 1476 |
Wednesday |
|
Compressed Sensing |
1477 - 1489 |
Thursday |
|
Image Reconstruction |
1490 - 1504 |
Monday |
|
Image Registration |
1505 - 1510 |
Tuesday |
|
Image Analysis - Parameter Mapping |
1511 - 1530 |
Wednesday |
|
Tissue Segmentation & Localization |
1531 - 1545 |
Thursday |
|
MR Elastography Methodology |
1546 - 1550 |
Tuesday |
|
MRS Methodology |
1551 - 1575 |
Wednesday |
|
Spectroscopy Methodology: Miscellaneous |
1576 - 1589 |
Thursday |
|
High Field Spectroscopic Quantitation &
Methodology |
1590 - 1617 |
Monday |
|
MRS Processing |
1618 - 1626 |
Tuesday |
|
NMR of Cells, Body Fluids & Other |
1627 - 1636 |
Wednesday |
|
Quantitative MRS of Glutathion 2 13C
Labeled Metabolites |
1637 - 1644 |
Thursday |
|
Molecular Imaging Agents: Applications &
Detection |
1645 - 1657 |
Monday |
|
Novel Molecular & Cellular Imaging Agents |
1658 - 1672 |
Tuesday |
|
Cell Labelling Applications |
1673 - 1694 |
Wednesday |
|
Multi-Modality Contrast Agents |
1695 - 1703 |
Thursday |
|
Perfusion & Permeability Methodology |
1704 - 1712 |
Monday |
|
MR Microscopy |
1713 - 1724 |
Tuesday |
|
Electron Spin Resonance/Oximetry |
1725 - 1733 |
Wednesday |
|
Non-Proton MRI |
1734 - 1744 |
Thursday |
|
Hyperpolarized 13C & Other Nuclei |
1745 - 1776 |
Monday |
|
Diffusion: Modeling |
1777 - 1786 |
Tuesday |
|
Diffusion - Biophysics |
1787 - 1797 |
Wednesday |
|
Diffusion Acquisition |
1798 - 1817 |
Thursday |
|
Diffusion: Artifacts, Phantoms, QA,
Reproducibility |
1818 - 1830 |
Monday |
|
Fiber Tracking & Connectivity Mapping |
1831 - 1855 |
Tuesday |
|
Crossing Fibers & Non-Tensor Approaches |
1856 - 1866 |
Wednesday |
|
Diffusion & Perfusion Studies in Animal
Models |
1867 - 1881 |
Thursday |
|
Perfusion & Permeability: Dynamic Contrast
Enhanced Methods |
1882 - 1894 |
Monday |
|
Perfusion & Permeability: Dynamic
Susceptibility Contrast Methods |
1895 - 1915 |
Tuesday |
|
Arterial Spin Labelling Methods |
1916 - 1932 |
Wednesday |
|
Animal Models & Cerebral Ischemia |
1933 - 1947 |
Thursday |
|
Imaging in Stroke: Clinical Studies |
1948 - 1964 |
Monday |
|
Clinical Imaging with DTI & fMRI |
1965 - 1976 |
Monday |
|
MRA & Flow: Physiology & Diseases |
1977 - 1996 |
Tuesday |
|
ENT: Tumors, Anatomy & Functional |
1997 - 2007 |
Wednesday |
|
Alzheimer's Disease & Mild Cognitive
Impairment |
2008 - 2035 |
Thursday |
|
Normal Human Brain: Connections &
Activations |
2036 - 2043 |
Monday |
|
Pediatric Normal Brain: Multimodality |
2044 - 2056 |
Tuesday |
|
Pediatric Brain: Metabolic, Leukodystrophy |
2057 - 2067 |
Wednesday |
|
Developmental Brain Disorders |
2068 - 2081 |
Thursday |
|
Drugs & the Developing Brain |
2082 - 2089 |
Monday |
|
The Aging Brain |
2090 - 2099 |
Tuesday |
|
Diabetes Mellitus & the CNS |
2100 - 2104 |
Wednesday |
|
Animal Models: Demyelination & Regeneration
in Brain & Spine |
2105 - 2116 |
Thursday |
|
Diffusion Measures of Disease in MS |
2117 - 2128 |
Monday |
|
Multiple Sclerosis: MR Analysis |
2129 - 2145 |
Tuesday |
|
Epilepsy |
2146 - 2157 |
Wednesday |
|
Mixed Brain Pathology |
2158 - 2189 |
Thursday |
|
Brain Tumor: Perfusion, Diffusion &
Contrast Techniques |
2190 - 2206 |
Monday |
|
Amyotrophic Lateral Sclerosis |
2207 - 2214 |
Tuesday |
|
Innovative Imaging of the Normal Brain |
2215 - 2247 |
Wednesday |
|
MRI/MRS of Psychiatric Disease |
2248 - 2267 |
Thursday |
|
Imaging Traumatic Brain & Spine Injury |
2268 - 2277 |
Monday |
|
Parkinson's Disease |
2278 - 2286 |
Tuesday |
|
Advanced Imaging of the Spine
& Spinal Cord |
2287 - 2304 |
Wednesday |
|
MRI of Animal Brain |
2305 - 2312 |
Thursday |
|
Manganese in the Brain: Method &
Application |
2313 - 2324 |
Monday |
|
MRS of Animal Brain |
2325 - 2337 |
Tuesday |
|
Physiological Characterization in fMR |
2338 - 2349 |
Wednesday |
|
fMRI: Mechanisms |
2350 - 2359 |
Thursday |
|
Novel fMRI Techniques |
2360 - 2381 |
Monday |
|
Non-BOLD Contrast |
2382 - 2396 |
Tuesday |
|
Functional Brain Networks & Connectivity |
2397 - 2420 |
Wednesday |
|
fMRI: Multimodal Integration |
2421 - 2433 |
Thursday |
|
fMRI: Animal Models |
2434 - 2448 |
Monday |
|
fMRI Correction Strategies |
2449 - 2463 |
Tuesday |
|
fMRI: Signal Variation & Noise |
2464 - 2477 |
Wednesday |
|
fMRI Analysis Methods |
2478 - 2491 |
Thursday |
|
phMRI |
2492 - 2500 |
Monday |
|
fMRI: Cognition & Other Non-Clinical
Applications |
2501 - 2507 |
Tuesday |
|
Ingestion, Drugs & Pain: Effects or fMRI
Signed |
2508 - 2516 |
Wednesday |
|
fMRI Applications |
2517 - 2524 |
Thursday |
|
Spine & Bone |
2525 - 2539 |
Monday |
|
Cartilage |
2540 - 2564 |
Wednesday |
|
Muscle |
2565 - 2598 |
Thursday |
|
Renal |
2599 - 2609 |
Monday |
|
Liver |
2610 - 2625 |
Tuesday |
|
Pancreatic Imaging |
2626 - 2629 |
Wednesday |
|
Lung MRI |
2630 - 2642 |
Thursday |
|
Hyperpolarized Gas Lung MRI |
2643 - 2681 |
Monday |
|
Body Animal Studies |
2682 - 2692 |
Tuesday |
|
Fetal & Uterine Imagery |
2693 - 2695 |
Wednesday |
|
Body Fat & Obesity |
2696 - 2706 |
Thursday |
|
Bowel Imaging |
2707 - 2712 |
Monday |
|
Whole Body Clinical Studies |
2713 - 2716 |
Tuesday |
|
Breast MR |
2717 - 2758 |
Wednesday |
|
Prostate Cancer |
2759 - 2779 |
Monday |
|
Advances in GI & Hepatobiliary |
2780 - 2781 |
Tuesday |
|
Tumor Perfusion & Permeability: Methodology
& Applications |
2782 - 2790 |
Wednesday |
|
Assessing Tumor Response to Therapy |
2791 - 2799 |
Thursday |
|
Ex Vivo MRS Studies of Tumor Metabolism |
2800 - 2804 |
Monday |
|
Preclinical MRI Cancer Monitoring |
2805 - 2813 |
Tuesday |
|
Brain Tumor: Spectroscopy, Susceptibility & Functional MR |
2814 - 2824 |
Wednesday |